Current and historical daily PE Ratio for Beijing Leadman Biochemistry Co Ltd (
) from 2012 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Leadman Biochemistry stock (SZSE:300289) PE ratio as of May 28 2024 is 503.33.
More Details
Beijing Leadman Biochemistry Co Ltd (SZSE:300289) PE Ratio (TTM) Chart
Beijing Leadman Biochemistry Co Ltd (SZSE:300289) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1192
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Beijing Leadman Biochemistry PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | 503.3 | 2024-03-19 | 169.0 |
| 2024-05-27 | 513.3 | 2024-03-18 | 169.7 |
| 2024-05-24 | 504.4 | 2024-03-15 | 165.9 |
| 2024-05-23 | 502.2 | 2024-03-14 | 163.4 |
| 2024-05-22 | 520.0 | 2024-03-13 | 162.4 |
| 2024-05-21 | 515.6 | 2024-03-12 | 162.8 |
| 2024-05-20 | 520.0 | 2024-03-11 | 158.3 |
| 2024-05-17 | 523.3 | 2024-03-08 | 155.9 |
| 2024-05-16 | 522.2 | 2024-03-07 | 154.8 |
| 2024-05-15 | 513.3 | 2024-03-06 | 156.9 |
| 2024-05-14 | 520.0 | 2024-03-05 | 155.5 |
| 2024-05-13 | 516.7 | 2024-03-04 | 161.0 |
| 2024-05-10 | 534.4 | 2024-03-01 | 159.0 |
| 2024-05-09 | 552.2 | 2024-02-29 | 155.2 |
| 2024-05-08 | 543.3 | 2024-02-28 | 150.7 |
| 2024-05-07 | 528.9 | 2024-02-27 | 167.2 |
| 2024-05-06 | 525.6 | 2024-02-26 | 162.1 |
| 2024-04-30 | 518.9 | 2024-02-23 | 159.3 |
| 2024-04-29 | 503.3 | 2024-02-22 | 153.1 |
| 2024-04-26 | 478.9 | 2024-02-21 | 148.3 |
| 2024-04-25 | 495.6 | 2024-02-20 | 144.1 |
| 2024-04-24 | 478.9 | 2024-02-19 | 142.4 |
| 2024-04-23 | 472.2 | 2024-02-08 | 135.9 |
| 2024-04-22 | 454.4 | 2024-02-07 | 122.8 |
| 2024-04-19 | 456.7 | 2024-02-06 | 134.8 |
| 2024-04-18 | 461.1 | 2024-02-05 | 134.5 |
| 2024-04-17 | 472.2 | 2024-02-02 | 155.5 |
| 2024-04-16 | 433.3 | 2024-02-01 | 165.2 |
| 2024-04-15 | 475.6 | 2024-01-31 | 170.3 |
| 2024-04-12 | 513.3 | 2024-01-30 | 180.7 |
| 2024-04-11 | 521.1 | 2024-01-29 | 189.7 |
| 2024-04-10 | 517.8 | 2024-01-26 | 193.4 |
| 2024-04-09 | 540.0 | 2024-01-25 | 192.1 |
| 2024-04-08 | 517.8 | 2024-01-24 | 182.8 |
| 2024-04-03 | 547.8 | 2024-01-23 | 179.3 |
| 2024-04-02 | 552.2 | 2024-01-22 | 182.1 |
| 2024-04-01 | 550.0 | 2024-01-19 | 194.5 |
| 2024-03-29 | 534.4 | 2024-01-18 | 195.9 |
| 2024-03-28 | 525.6 | 2024-01-17 | 200.7 |
| 2024-03-27 | 161.7 | 2024-01-16 | 205.5 |
| 2024-03-26 | 164.5 | 2024-01-15 | 206.9 |
| 2024-03-25 | 165.9 | 2024-01-12 | 204.8 |
| 2024-03-22 | 169.0 | 2024-01-11 | 207.9 |
| 2024-03-21 | 173.4 | 2024-01-10 | 207.2 |
| 2024-03-20 | 173.1 | 2024-01-09 | 210.0 |
Beijing Leadman Biochemistry Co Ltd (SZSE:300289) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beijing Leadman Biochemistry Co Ltd
NAICS : 325413
SIC : 2835
ISIN : CNE100001C22
Share Class Description:
SZSE:300289: Class ACompare
Compare
Traded in other countries / regions
300289.China IPO Date
2012-02-16Description
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers